Glossary entry (derived from question below)
English term or phrase:
immune confirmed progressive disease (“iCPD”) by iRECIST
Italian translation:
malattia progressiva immunologicamente confermata (= con metodiche/tecniche immunologiche) secondo i criteri iRECIST
Added to glossary by
martini
Aug 16, 2023 13:37
9 mos ago
22 viewers *
English term
Italy
Medicine, Pharmacology, Medical Devices
Native in: Italian 
Works in: English to Italian
immune confirmed progressive disease (“iCPD”) by iRECIST
English to Italian
Medical
Medical: Pharmaceuticals
CONTESTO:
Screening and then at 12 weeks (±1 week) from treatment start (first exposure) and thereafter every 8 weeks ± 1 week until immune confirmed progressive disease (“iCPD”) by iRECIST, discontinuation of study drug(s), withdrawal of consent or loss to follow-up.
interpreto (e traduco) ...immune confirmed progressive disease (“iCPD”) by iRECIST... con "Malattia progressiva immunologicamente confermata (“iCPD”) secondo i criteri iRECIST"
attendo conferma (o smentita :) )
Grazie
Rino
Screening and then at 12 weeks (±1 week) from treatment start (first exposure) and thereafter every 8 weeks ± 1 week until immune confirmed progressive disease (“iCPD”) by iRECIST, discontinuation of study drug(s), withdrawal of consent or loss to follow-up.
interpreto (e traduco) ...immune confirmed progressive disease (“iCPD”) by iRECIST... con "Malattia progressiva immunologicamente confermata (“iCPD”) secondo i criteri iRECIST"
attendo conferma (o smentita :) )
Grazie
Rino
Proposed translations
(Italian)
Change log
Aug 21, 2023 15:22: martini Created KOG entry
Proposed translations
16 mins
Selected
malattia progressiva confermata dal sistema immunitario secondo i criteri iRECIST
ho trovato questo
iCPD: malattia progressiva confermata dal sistema immunitario
utilizzando i criteri di valutazione della risposta immunitaria nei criteri dei tumori solidi (iRECIST 1.1)
https://ichgcp.net/it/clinical-trials-registry/NCT03179410
iCPD: malattia progressiva confermata dal sistema immunitario
utilizzando i criteri di valutazione della risposta immunitaria nei criteri dei tumori solidi (iRECIST 1.1)
https://ichgcp.net/it/clinical-trials-registry/NCT03179410
3 KudoZ points awarded for this answer.
Comment: "Concettualmente sono d'accordo. Allora utilizzerei ciò che ho presupposto nella mia domanda: "malattia progressiva immunologicamente confermata (= con metodiche/tecniche immunologiche) secondo i criteri iRECIST"."
+1
2 hrs
malattia progressiva confermata (iCPD) secondo i criteri iRECIST
..
--------------------------------------------------
Note added at 2 heures (2023-08-16 16:34:38 GMT)
--------------------------------------------------
imune is in the acronymn "iRECIST
--------------------------------------------------
Note added at 2 heures (2023-08-16 16:34:56 GMT)
--------------------------------------------------
see
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648544/
“i” indicates immune responses assigned using iRECIST. RECIST=Response Evaluation Criteria in Solid Tumours. iUPD=unconfirmed progression. iCPD=confirmed progression. iCR=complete response. iPR=partial response. iSD=stable disease.
--------------------------------------------------
Note added at 2 heures (2023-08-16 16:34:38 GMT)
--------------------------------------------------
imune is in the acronymn "iRECIST
--------------------------------------------------
Note added at 2 heures (2023-08-16 16:34:56 GMT)
--------------------------------------------------
see
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648544/
“i” indicates immune responses assigned using iRECIST. RECIST=Response Evaluation Criteria in Solid Tumours. iUPD=unconfirmed progression. iCPD=confirmed progression. iCR=complete response. iPR=partial response. iSD=stable disease.
Note from asker:
| ....e "imune"? |
Peer comment(s):
| agree |
EleoE
: iRECIST = response evaluation criteria in solid tumors modified for immune-based therapeutics.
3 hrs
|
|
Grazie!
|
7 hrs
Cristina Bufi Poecksteiner, M.A.
Austria
Austria
Native in Italian
Specializes in field
Austria
Cristina Bufi Poecksteiner, M.A.
BDÜ Law Marketing Med Techn - since 1990
Native in: Italian
Works in: German to Italian, English to Italian, French to Italian, and 11 more.
Related KudoZ points
:
91
malattia immun. progressiva confermata (iCPD) mediante criteri di risposta immunocorrelati (iRECIST)
immune confirmed progressive disease (iCPD) by iRECIST = malattia immunitaria progressiva confermata (iCPD) mediante criteri di risposta immunocorrelati (iRECIST)
iRECIST
A guideline for data management and data collection for trials testing immunotherapeutics
# MD, PhD
Canadian Cancer Trials Group, Kingston, Ontario
On behalf of the RECIST Working Group (RWG) and
Immunotherapy Subcommittee
... Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
https://recist.eortc.org/recist/wp-content/uploads/sites/4/2...
I nuovi criteri di risposta immunocorrelati (iRECIST): sono sempre adeguati?
Fondazione IRCCS
Istituto Nazionale dei Tumori Milano
Criteri di risposta
- Gruppo di regole atte ad identificare il comportamento di una neoplasia durante un trattamento
- Linguaggio comune standardizzato per la misurazione della risposta dei tumori al trattamento
- Mirano a garantire l’obiettività ed a ridurre la variabilità tra osservatori
- Indispensabili per comparare risultati di studi differenti
Criteri radiologici di risposta
- Registrano le variazioni (principalmente dimensionali) di un tumore primario e delle sue lesioni secondarie al fine di valutare l’attività delle terapie antineoplastiche
https://www.aiom.it/wp-content/uploads/2019/02/20190524RM_22...
--------------------------------------------------
Note added at 7 hrs (2023-08-16 21:04:07 GMT)
--------------------------------------------------
1° link :
iRECIST
A guideline for data management and data collection for trials testing immunotherapeutics
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
iRECIST
A guideline for data management and data collection for trials testing immunotherapeutics
# MD, PhD
Canadian Cancer Trials Group, Kingston, Ontario
On behalf of the RECIST Working Group (RWG) and
Immunotherapy Subcommittee
... Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
https://recist.eortc.org/recist/wp-content/uploads/sites/4/2...
--------------------------------------------------
Note added at 7 hrs (2023-08-16 21:12:51 GMT)
--------------------------------------------------
senza specificare
immune confirmed progressive disease (iCPD) by iRECIST = malattia immunitaria progressiva confermata (iCPD) da / mediante iRECIST
iRECIST
A guideline for data management and data collection for trials testing immunotherapeutics
# MD, PhD
Canadian Cancer Trials Group, Kingston, Ontario
On behalf of the RECIST Working Group (RWG) and
Immunotherapy Subcommittee
... Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
https://recist.eortc.org/recist/wp-content/uploads/sites/4/2...
I nuovi criteri di risposta immunocorrelati (iRECIST): sono sempre adeguati?
Fondazione IRCCS
Istituto Nazionale dei Tumori Milano
Criteri di risposta
- Gruppo di regole atte ad identificare il comportamento di una neoplasia durante un trattamento
- Linguaggio comune standardizzato per la misurazione della risposta dei tumori al trattamento
- Mirano a garantire l’obiettività ed a ridurre la variabilità tra osservatori
- Indispensabili per comparare risultati di studi differenti
Criteri radiologici di risposta
- Registrano le variazioni (principalmente dimensionali) di un tumore primario e delle sue lesioni secondarie al fine di valutare l’attività delle terapie antineoplastiche
https://www.aiom.it/wp-content/uploads/2019/02/20190524RM_22...
--------------------------------------------------
Note added at 7 hrs (2023-08-16 21:04:07 GMT)
--------------------------------------------------
1° link :
iRECIST
A guideline for data management and data collection for trials testing immunotherapeutics
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
iRECIST
A guideline for data management and data collection for trials testing immunotherapeutics
# MD, PhD
Canadian Cancer Trials Group, Kingston, Ontario
On behalf of the RECIST Working Group (RWG) and
Immunotherapy Subcommittee
... Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
https://recist.eortc.org/recist/wp-content/uploads/sites/4/2...
--------------------------------------------------
Note added at 7 hrs (2023-08-16 21:12:51 GMT)
--------------------------------------------------
senza specificare
immune confirmed progressive disease (iCPD) by iRECIST = malattia immunitaria progressiva confermata (iCPD) da / mediante iRECIST
Reference comments
1 hr
Reference:
see
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648544/
“i” indicates immune responses assigned using iRECIST. RECIST=Response Evaluation Criteria in Solid Tumours. iUPD=unconfirmed progression. iCPD=confirmed progression. iCR=complete response. iPR=partial response. iSD=stable disease.
--------------------------------------------------
Note added at 1 heure (2023-08-16 15:30:13 GMT)
--------------------------------------------------
iRECIST (immunotherapy RECIST)
--------------------------------------------------
Note added at 1 heure (2023-08-16 15:36:31 GMT)
--------------------------------------------------
Patterns of Response and Progression to Immunotherapy
ASCO Journals
https://ascopubs.org › doi › EDBK_200643
by E Borcoman · Cited by 220 — In March 2017, a consensus guideline named immunotherapy RECIST (iRECIST) was published after extensive work carried out by the RECIST working group along ...
--------------------------------------------------
Note added at 2 heures (2023-08-16 15:46:42 GMT)
--------------------------------------------------
CM082 più JS001 nel Carcinoma polmonare non a piccole cellule ...
https://ichgcp.net › NCT03848611
I soggetti identificati come **** malattia progressiva confermata (iCPD) secondo i criteri iRECIST**** devono interrompere il trattamento.
“i” indicates immune responses assigned using iRECIST. RECIST=Response Evaluation Criteria in Solid Tumours. iUPD=unconfirmed progression. iCPD=confirmed progression. iCR=complete response. iPR=partial response. iSD=stable disease.
--------------------------------------------------
Note added at 1 heure (2023-08-16 15:30:13 GMT)
--------------------------------------------------
iRECIST (immunotherapy RECIST)
--------------------------------------------------
Note added at 1 heure (2023-08-16 15:36:31 GMT)
--------------------------------------------------
Patterns of Response and Progression to Immunotherapy
ASCO Journals
https://ascopubs.org › doi › EDBK_200643
by E Borcoman · Cited by 220 — In March 2017, a consensus guideline named immunotherapy RECIST (iRECIST) was published after extensive work carried out by the RECIST working group along ...
--------------------------------------------------
Note added at 2 heures (2023-08-16 15:46:42 GMT)
--------------------------------------------------
CM082 più JS001 nel Carcinoma polmonare non a piccole cellule ...
https://ichgcp.net › NCT03848611
I soggetti identificati come **** malattia progressiva confermata (iCPD) secondo i criteri iRECIST**** devono interrompere il trattamento.
Something went wrong...